- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
June 7, 2023Partner Tim Billion Honored With 2023 Appellate Advocacy Award
-
June 6, 2023Super Lawyers Names Five Attorneys to “Southern California Rising Stars” List
-
June 1, 2023Chambers USA Recognizes Five Robins Kaplan Practice Groups and 17 Lawyers in 2023 Guide
-
June 13, 20232023 Probate and Trust Law Section Conference
-
June 14, 2023Leading Through Uncertainty
-
June 15, 2023Enhance Your Super Powers by Clerking
-
May 2023Raoul Shah: Keeping Humanity and Compassion Close
-
May 18, 2023NFT Trademark Defense Comes Down To Licensing Terms
-
April 20, 2023Drafting Subsequent Agreements to Avoid Arbitrability Litigation
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Consumer Alert: Yaz, Yasmin and Ocella's Dangerous Side Effects
July 12, 2010
Copyright 2010. All rights reserved.
Birth control pills Yaz, Yasmin and the generic Ocella have a unique ingredient called drospirenone, a synthetic progestin, which is not found in other birth control pills. Drospirenone has been associated with a number of severe side effects. Reported serious side effects include blood clots, as two recent epidemiological studies of pills containing drospirenone have found that these were associated with a higher risk of blood clots than some other oral contraceptives without drospirenone.[1] There have also been reports that drospirenone-containing pills may increase potassium levels, which can lead to hyperkalemia, a condition which can lead to serious heart rhythm disturbances.[2] Additionally, oral contraceptives are associated with an increased risk of gallstones and gallbladder disease.[3] In February 2010, Bayer started a $20 million dollar corrective advertising campaign for Yaz after the FDA found the company overstated the drug's benefits while minimizing its risks.[4]
Robins, Kaplan, Miller & Ciresi L.L.P. is investigating potential claims on behalf of Yaz, Yasmin and Ocella patients. If you wish to speak to us about a potential claim or an injury caused by Yaz, Yasmin or Ocella birth control pills, please call Kathy Neuman, R.N., B.S.N. at 1-800-553-9910 or contact her via email at contact us.
[2] R Schurmann et al. Effect of Drospirenone on Serum Potassium and Drospirenone Pharmacokinetics in Women With Normal or Impaired Renal Function. J Clin Pharmacol. 2006; 46: 867-875.
[3] C. Thijs et al. Oral Contraceptives and the Risk of Gallbladder Disease: A Meta-Analysis. Am J Public Health. 1993 Aug; 83: 1113-1120.
[4] http://www.nytimes.com/2009/02/11/business/11pill.html
The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.
Related Professionals
Kate E. Jaycox
Partner
Related Publications
Related News
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.